NTRK1 and central nervous system cancer: In pediatric high-grade gliomas, TRK gene fusions frequently serve as the sole oncogenic drivers and may initiate tumorigenesis, activating both the PI3K-AKT and RAF-MEK-ERK pathways [87,88,89].